SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $396,063 | -92.9% | 15,387 | -92.8% | 0.00% | -93.9% |
| Q4 2022 | $5,576,726 | +14.4% | 214,407 | +25.5% | 0.03% | +22.2% |
| Q3 2022 | $4,876,000 | +45.1% | 170,901 | +25.2% | 0.03% | +28.6% |
| Q2 2022 | $3,361,000 | +422.7% | 136,515 | +1216.4% | 0.02% | +250.0% |
| Q4 2021 | $643,000 | -24.1% | 10,370 | -22.4% | 0.01% | -45.5% |
| Q3 2021 | $847,000 | -55.1% | 13,358 | -41.7% | 0.01% | -47.6% |
| Q2 2021 | $1,887,000 | -5.7% | 22,902 | -15.8% | 0.02% | -19.2% |
| Q1 2021 | $2,001,000 | +120.9% | 27,196 | +117.6% | 0.03% | +116.7% |
| Q4 2020 | $906,000 | +1252.2% | 12,496 | +794.5% | 0.01% | +1100.0% |
| Q3 2020 | $67,000 | -35.0% | 1,397 | -43.0% | 0.00% | -50.0% |
| Q2 2020 | $103,000 | +472.2% | 2,450 | +261.4% | 0.00% | – |
| Q1 2020 | $18,000 | – | 678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |